STSN — Stemsation International Share Price
- $1.68m
- $1.99m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | n/a | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | n/a | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | n/a | ||
Return on Equity | n/a | ||
Operating Margin | n/a |
Financial Summary
Year End 31st Dec | Unit | 2014 | 2015 | 2016 | 2017 | 2018 | 2019E | 2020E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | n/a | n/a | 0 | n/a | n/a | n/a | n/a | n/a |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
StemSation International, Inc. is engaged in researching the developing, marketing and distribution of flavored, canned oxygen products. These products are distributed in a lifestyle model to the beverage industry as well as colleges, restaurants and bars. The Company, through Gorilla Marketing Group, LLC (GMG), is an owner and distributor of high-end vape products under the brand, AlienHouse. The products include disposable vape cartridges in a range of flavors along with THC-P hemp derivatives. It also markets its branded, Zombie-themed apparel and marketing materials. The Company is also seeking acquisitions to complement their current products.
Directors
- Last Annual
- December 31st, 2018
- Last Interim
- September 30th, 2011
- Incorporated
- July 5th, 2006
- Public Since
- January 28th, 2008
- No. of Employees
- 5
- Sector
- Specialty Retailers
- Industry
- Consumer Cyclicals
- Exchange
Pink Sheets on Nasdaq
- Shares in Issue
- 262,401,258

- Address
- 1537 NW 65th Avenue, PLANTATION, 33313
- Web
- Phone
- +1 4042558800
- Auditors
- Unaudited
Similar to STSN
Arion
Pink Sheets on Nasdaq
Avolta AG
Pink Sheets on Nasdaq
bebe stores
Pink Sheets on Nasdaq
Beter Bed Holding BV
Pink Sheets on Nasdaq
Better for You Wellness
Pink Sheets on Nasdaq
FAQ
As of Today at 23:26 UTC, shares in Stemsation International are trading at $0.01. This share price information is delayed by 15 minutes.
Shares in Stemsation International last closed at $0.01 and the price had moved by -67.9% over the past 365 days. In terms of relative price strength the Stemsation International share price has underperformed the S&P500 Index by -70.01% over the past year.
There is no consensus recommendation for this security.
Find out moreStemsation International does not currently pay a dividend.
Stemsation International does not currently pay a dividend.
Stemsation International does not currently pay a dividend.
To buy shares in Stemsation International you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.01, shares in Stemsation International had a market capitalisation of $1.68m.
Here are the trading details for Stemsation International:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: STSN
Based on an overall assessment of its quality, value and momentum Stemsation International is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Stemsation International. Over the past six months, its share price has underperformed the S&P500 Index by -74.44%.
As of the last closing price of $0.01, shares in Stemsation International were trading -68.6% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Stemsation International PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.01.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Stemsation International's management team is headed by:
- Ray Carter - PRE
- David Casanova - SVP
- Mira Gadzala - CSO
- Nick Panza - VOP